United States · Platforms & data · MarketBeat

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Target Cut by Needham & Company LLC

Published by MarketBeat · United States 2 h ago

Needham & Company LLC lowered their price target on Rhythm Pharmaceuticals from $130.00 to $114.00 and set a "buy" rating on the stock in a report on Tuesday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

USANA Health Sciences Non-GAAP EPS of -$0.11 misses by $0.22, revenue of $205.89M misses by $11.53M

The Motley Fool

Douglas Dynamics (PLOW) Q3 2026 Earnings Call Transcript

MarketWatch

S&P 500 is looking over the edge of a technical cliff — what happens if it falls off?

Investing.com

Postal Realty earnings missed by $0.01, revenue topped estimates

CNBC

Stock market after midterm elections: What S&P 500 history shows

Benzinga